The pathophysiology of hemophagocytic lympho-histiocytosis (HLH) syndrome and insights from animal models
Clinical and Experimental Immunology · 2025
DOI: 10.1093/cei/uxaf036 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Experimental Immunology, 2025. Verfasst von Sayan Mukherjee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology and Rheumatology, King George Medical University, Lucknow, India. Hauptthemen laut MEDLINE: Lymphohistiocytosis, Hemophagocytic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Hemophagocytic lymphohistiocytosis (HLH) is a severe hyperinflammatory syndrome characterized by an aberrant immune response against host tissues. It can arise from diverse triggers like infection, inflammation, malignancy, genetic defects, or therapy-related factors. Cytokine storm, capillary leak syndrome, cytokine release syndrome, and macrophage activation syndrome are the different faces of this chimera, and each of them displays significant clinical variability associated with high mortality. The pathogenesis of both primary and secondary HLH generally follows a similar pattern, involving excessive activation of macrophages and uncontrolled destruction of reticuloendothelial tissues. Environmental triggers cause exaggerated activation of innate immune cells in genetically predisposed individuals. This process is further driven by the release of multiple cytokines and soluble mediators that sustain ongoing inflammation and cause subsequent target organ damage. Biomarkers, including cytokines and inflammatory mediators, are crucial for early detection and monitoring treatment response. Persistent immune activation and inadequate resolution mechanisms result in a destructive inflammatory cascade or “immunological massacre”. Animal models of HLH and MAS elucidate the roles of impaired cytotoxicity, IFN-γ, TLR signaling, and inflammatory cytokines in disease pathogenesis. Trigger-specific differences highlight the involvement of CD8+ T cells, NK cells, macrophages, and cytokines. Therapeutic strategies include cytokine neutralization, adoptive T-cell transfer, and mTOR inhibition. Timely diagnosis and prompt initiation of therapy are essential to mitigate the serious consequences of HLH and improve long-term outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Immunology and Rheumatology, King George Medical University, Lucknow, India.
ORCID-Profile: Sayan Mukherjee
Zitieren
APA
Mukherjee, S., & Kumar, P. (2025). The pathophysiology of hemophagocytic lympho-histiocytosis (HLH) syndrome and insights from animal models. Clinical and Experimental Immunology. https://doi.org/10.1093/cei/uxaf036
Vancouver
Mukherjee S, Kumar P. The pathophysiology of hemophagocytic lympho-histiocytosis (HLH) syndrome and insights from animal models. Clinical and Experimental Immunology. 2025. doi:10.1093/cei/uxaf036
BibTeX
@article{Mukherjee2025,
author = {Mukherjee, Sayan and Kumar, Puneet},
title = {The pathophysiology of hemophagocytic lympho-histiocytosis (HLH) syndrome and insights from animal models},
journal = {Clinical and Experimental Immunology},
year = {2025},
doi = {10.1093/cei/uxaf036}
}
EUVIMED